MEET THE EXPERT: THE ROLE OF PARP INHIBITORS IN OVARIAN CANCER: FIRST-LINE TREATMENT ALGORITHM, OUTCOMES, AND SURVIVAL

• NICOLETTA COLOMBO· PROFESSORE
• FEDERICA TOMAO· PROFESSORE

• NICOLETTA COLOMBO· RELATORE
• FEDERICA TOMAO· RELATORE
• FEDERICA TOMAO· MODERATORE

Ragione sociale

MI&T SRL

Stato accreditamento

STANDARD - 1° rinnovo

Di sistema

This “meet the expert” is designed to provide an interactive discussion between faculty and participants, focusing on real-world application of current evidence, treatment decision-making, and management of clinical scenarios in ovarian cancer. The goal is to enhance clinicians’ understanding of the role of parp inhibitors and support evidence-based, patient-centered therapeutic choices.

#2Linee guida - protocolli - procedure

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

100

Verifica presenza

Firma Di Presenza

Verifica apprendimento

Questionario A Risposta Multipla